Journal
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
Volume 38, Issue 4, Pages 571-573Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RCT.0000000000000086
Keywords
ferumoxytol; ultrasmall superparamagnetic iron oxide nanoparticles; mimic hemosiderosis; magnetic resonance imaging (MRI)
Ask authors/readers for more resources
Ferumoxytol is a parenteral iron therapy that the Food and Drug Administration recently approved for the treatment of iron-deficiency anemia. The form of the iron, ultrasmall superparamagnetic iron oxide nanoparticles, causes T1, T2, and T2* shortening on magnetic resonance imaging, which can mimic hemosiderosis. We report such a case, with laboratory findings that demonstrate normal iron stores, and discuss the potential implications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available